↓ Skip to main content

American Association for Cancer Research

A Randomized Double-blind Placebo-controlled Trial of Oral Aspirin for Protection of Melanocytic Nevi Against UV-induced DNA Damage

Overview of attention for article published in Cancer Prevention Research, February 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
9 Mendeley
Title
A Randomized Double-blind Placebo-controlled Trial of Oral Aspirin for Protection of Melanocytic Nevi Against UV-induced DNA Damage
Published in
Cancer Prevention Research, February 2022
DOI 10.1158/1940-6207.capr-21-0399
Pubmed ID
Authors

Nwanneka Okwundu, Hafeez Rahman, Tong Liu, Scott R. Florell, Kenneth M. Boucher, Douglas Grossman

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 22%
Researcher 2 22%
Other 1 11%
Unknown 4 44%
Readers by discipline Count As %
Unspecified 2 22%
Medicine and Dentistry 2 22%
Biochemistry, Genetics and Molecular Biology 1 11%
Unknown 4 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2023.
All research outputs
#7,008,987
of 25,611,630 outputs
Outputs from Cancer Prevention Research
#569
of 1,456 outputs
Outputs of similar age
#149,878
of 523,418 outputs
Outputs of similar age from Cancer Prevention Research
#10
of 36 outputs
Altmetric has tracked 25,611,630 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 1,456 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.7. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 523,418 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.